Press Release

PhRMA Names Bob Filippone Senior VP of Federal Advocacy

PhRMA April 29, 2013

Washington, D.C. (March 10, 2011) — The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced that Robert J. Filippone, PhD, has been named Senior Vice President of Federal Advocacy, effective immediately. Dr. Filippone will report to Executive Vice President of Advocacy Chip Davis.

A six-year veteran of PhRMA, Dr. Filippone has served as Vice President of Federal Government Affairs since January 2009. In his expanded role, he will oversee PhRMA’s federal advocacy functions.

“Bob has a distinguished record representing the interests of the innovative biopharmaceutical sector and the patients we serve, both domestically and abroad,” Davis said. “His judgment, professionalism and commitment are above reproach. Working with stakeholders across the spectrum, he will play a critically important role in leading our integrated advocacy efforts moving forward.”

“I’m honored to have the opportunity to continue working with PhRMA’s outstanding team and its member companies,” said Dr. Filippone. “I look forward to meeting the challenges facing our innovative industry and helping it bring even greater value to patients throughout the world, American workers and our economy.”

During his tenure at PhRMA, Dr. Filippone has managed domestic and international policy issues, with a particular focus on the critical role intellectual property plays in the discovery of new medicines, as well as policies in foreign markets that provide patient access to innovative pharmaceutical products. He is a recent recipient of the PhRMA Board of Directors Exceptional Service Award for leading industry advocacy efforts.

Dr. Filippone came to PhRMA in 2004 after serving over eight years in the United States Senate, where he held a variety of senior positions on both personal and committee staffs. Prior to his Senate service, he worked as a national security specialist in the Office of the Secretary of Defense, a missile systems engineer for Raytheon Company, and Director of Research and Adjunct Professor at the Fletcher School of Law and Diplomacy.

In addition to a doctorate in philosophy/international relations from the Fletcher School of Law and Diplomacy, Dr. Filippone holds a master of arts in law and diplomacy from Fletcher, as well as a master of biomedical engineering degree and an undergraduate degree in mechanical engineering from Worcester Polytechnic Institute.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $45.8 billion in 2009 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.3 billion in 2009.

PhRMA Internet Address:
For information on how innovative medicines save lives, visit:
For information on the Partnership for Prescription Assistance, visit:
For more information on public health emergencies, visit
For information on the danger of imported drugs, visit: